* Biote Corp BTMD.OQ reported a quarterly adjusted loss
of 6
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -39
cents. The mean expectation of four analysts for the quarter
was for earnings of 3 cents per share. Wall Street expected
results to range from -1 cents to 9 cents per share.
* Revenue rose 4.4% to $46.80 million from a year ago;
analysts
expected $45.71 million.
* Biote Corp's reported EPS for the quarter was a loss of 6
cents.
* The company reported a quarterly loss of $2.07 million.
* Biote Corp shares had fallen by 0.5% this quarter and
gained 16.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 39.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the professional
information services peer group is also "buy"
Wall Street's median 12-month price target for Biote Corp is
$9.00
This summary was machine generated from LSEG data May 8 at 11:29
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.03 -0.06 Missed
Dec. 31 2023 0.08 0.18 Beat
Sep. 30 2023 0.08 0.24 Beat
Jun. 30 2023 0.10 -0.25 Missed